Current role
Biotechnology · Healthcare
CEO, Board Member
2018-01-01–present
Bradley Burnam
Board Member
Turn Therapeutics Inc. (TTRX)Equibles does not estimate personal net worth.
About Bradley Burnam
Bradley Burnam is recorded as Board Member at Turn Therapeutics Inc. (TTRX) since January 1, 2018 and CEO at Turn Therapeutics Inc. (TTRX). The newest filing on record that lists Bradley Burnam as CEO and Board Member at Turn Therapeutics Inc. (TTRX) is dated October 19, 2026. The proxy statement of Turn Therapeutics Inc. reports total compensation of $652,036 for Bradley Burnam in fiscal 2025, including a base salary of $465,740. Disclosed compensation is on record for 2 fiscal years. Turn Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Turn Therapeutics Inc. includes Zuraiz Chaudhary (CFO), Andrew Gengos (Board Member), Arthur Golden (Board Member) and 3 others.
Affiliation history
-
Current
2018-01-01–present
Last confirmed October 19, 2026
-
Current
Start not stated–present
Last confirmed October 19, 2026
Company network
Leadership on record at Turn Therapeutics Inc.
- Zuraiz Chaudhary CFO
- Andrew Gengos Board Member
- Arthur Golden Board Member
- Dr. Kent Kester Board Member
- Dr. Neil Ghodadra Board Member
- Martin Dewhurst Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Turn Therapeutics Inc. (TTRX) | Chief Executive Officer | $465,740 | $652,036 |
| 2024 | Turn Therapeutics Inc. (TTRX) | Chief Executive Officer | $429,320 | $429,320 |
Recent activity
No call appearances or filed executive changes recorded yet.